[1]
“Profile of the consumption of antidepressants and benzodiazepines in a UBS in the Federal District during the COVID-19 Pandemic”, RSD, vol. 12, no. 3, p. e28112340857, Mar. 2023, doi: 10.33448/rsd-v12i3.40857.